Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Respiratory Compromise Institute (RCI) is a non-profit coalition of professional medical societies and healthcare providers dedicated to reducing preventable adverse events and deaths related to respiratory compromise. Founded in 2015, the institute focuses on defining respiratory compromise as a clinical state and educating the medical community on early detection and mitigation strategies. RCI advocates for the use of continuous monitoring technologies, such as capnography and pulse oximetry, to identify patients at risk of respiratory failure in hospital and home settings. The organization supports research, develops educational resources, and fosters multidisciplinary dialogue among pulmonologists, anesthesiologists, and other specialists to improve patient safety.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Respiratory Compromise Institute.